ClinicalTrials.gov
ClinicalTrials.gov Menu

Biological Efficacy Study of HerpV Vaccine With QS-21 to Treat Subjects With Recurrent Genital Herpes

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01687595
Recruitment Status : Completed
First Posted : September 19, 2012
Last Update Posted : January 26, 2015
Sponsor:
Information provided by (Responsible Party):
Agenus Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : September 2013
  Actual Study Completion Date : January 2015
  Certification/Extension First Submitted : January 12, 2015